South Africa begins search for new reactor to sustain Molybdenum-99 output

The country is one of world’s top producers of Molybdenum-99 used in medical diagnostic imaging.
Image: Necsa website

South Africa’s state-owned nuclear energy firm, Necsa, on Monday launched a tender to replace its ageing nuclear research reactor, Safari 1, and help maintain its position as one of the world’s top producers of Molybdenum-99 used in medical diagnostic imaging.

Molybdenum-99, or Mo-99, is used in millions of diagnostic tests for cancer, heart disease and other illnesses worldwide.

NTP Radioisotopes is a subsidiary of the South African Nuclear Energy Corporation (Necsa) and uses the 20 megawatt Safari 1 research reactor at Pelindaba, in operation since 1965, to produce Mo-99.

The plant had to be shutdown for three months at the beginning of 2018 after a hydrogen leak was detected.

It is currently in care and maintenance, Necsa said, as it released a request for information (RFI) to the market on Monday, the first step in a tender process to help gauge appetite from a potential preferred supplier to construct a new multi-purpose reactor (MPR).

“The MPR will continue with the legacy of producing medical radioisotopes, which are used to treat thousands of patients diagnosed with cancer all over the world,” Loyiso Tyabashe, group chief executive at Necsa, said in a statement.

The NTP is a top four global supplier of medical radioisotopes to the United States, Japan and countries in Europe and the Middle East, Necsa said.

The request for information ends on March 10, the company added.

COMMENTS   1

You must be signed in and an Insider Gold subscriber to comment.

SUBSCRIBE NOW SIGN IN

If the USSR saw fit to deploy cadres at Chernobil, what prevents Luthuli House from deploying cadres at Pelindaba?

End of comments.

LATEST CURRENCIES  

USD / ZAR
GBP / ZAR
EUR / ZAR
BTC / USD

Podcasts

Instrument Details  

You do not have any portfolios, please create one here.
You do not have an alert portfolio, please create one here.
INSIDER SUBSCRIPTION APP VIDEOS RADIO / LISTEN LIVE SHOP OFFERS WEBINARS NEWSLETTERS TRENDING

Follow us: